<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Elevated level of osteoprotegerin (OPG), a pleiotropic cytokine involved in bone metabolism, has been associated with <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> and higher cardiovascular mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Because <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e> are recognized risk factors for <z:hpo ids='HP_0000726'>dementia</z:hpo>, the study of OPG as a disease marker in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) seemed worthy of investigation </plain></SENT>
<SENT sid="2" pm="."><plain>OPG concentration was determined by ELISA in an Italian cohort consisting of 39 VaD patients, 36 AD patients, and 39 non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> controls strictly matched for age and gender </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma OPG levels were positively related to age in both <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> and non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> persons </plain></SENT>
<SENT sid="4" pm="."><plain>OPG concentrations were significantly higher in both VaD (median: 4.75 pmol/l; interquartile range: 3.42-6.85 pmol/l; P&lt;0.0001) and AD (median: 4.02 pmol/l; interquartile range: 3.07-4.77 pmol/l; P=0.0278) compared to non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> controls (median: 3.24 pmol/l, interquartile range: 2.70-3.98 pmol/l) </plain></SENT>
<SENT sid="5" pm="."><plain>After allowance for confounding factors (age, gender and APOE epsilon4 allele), plasma OPG levels remained independently associated with the presence of VaD (OR = 2.51; 95% CI 1.46-4.32; P=0.0009) and AD (OR = 2.17; 95% CI 1.18-3.99; P=0.0126) </plain></SENT>
<SENT sid="6" pm="."><plain>Our study demonstrates that OPG may be regarded as a novel biomarker of <z:hpo ids='HP_0000726'>dementia</z:hpo> in the Italian population </plain></SENT>
<SENT sid="7" pm="."><plain>These results further support the hypothesis that vascular factors may not only play a role in the pathogenesis of VaD but also in the pathogenesis of AD </plain></SENT>
</text></document>